245 related articles for article (PubMed ID: 29497164)
21. Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype.
Ziauddeen H; Nestor LJ; Subramaniam N; Dodds C; Nathan PJ; Miller SR; Sarai BK; Maltby K; Fernando D; Warren L; Hosking LK; Waterworth D; Korzeniowska A; Win B; Richards DB; Vasist Johnson L; Fletcher PC; Bullmore ET
Neuropsychopharmacology; 2016 Oct; 41(11):2647-57. PubMed ID: 27109624
[TBL] [Abstract][Full Text] [Related]
22. Association of the
Sebold M; Garbusow M; Cerci D; Chen K; Sommer C; Huys QJ; Nebe S; Rapp M; Veer IM; Zimmermann US; Smolka MN; Walter H; Heinz A; Friedel E
J Psychopharmacol; 2021 May; 35(5):566-578. PubMed ID: 33726538
[TBL] [Abstract][Full Text] [Related]
23. Initial evidence that OPRM1 genotype moderates ventral and dorsal striatum functional connectivity during alcohol cues.
Ray LA; Courtney KE; Hutchison KE; Mackillop J; Galvan A; Ghahremani DG
Alcohol Clin Exp Res; 2014 Jan; 38(1):78-89. PubMed ID: 23876228
[TBL] [Abstract][Full Text] [Related]
24. Pharmacogenetic Effects of Naltrexone in Individuals of East Asian Descent: Human Laboratory Findings from a Randomized Trial.
Ray LA; Green R; Roche DJO; Bujarski S; Hartwell EE; Lim AC; Rohrbaugh T; Ghahremani D; Hutchison K; Miotto K
Alcohol Clin Exp Res; 2018 Mar; 42(3):613-623. PubMed ID: 29265379
[TBL] [Abstract][Full Text] [Related]
25. Preliminary evidence for a gene-environment interaction in predicting alcohol use disorders in adolescents.
Miranda R; Reynolds E; Ray L; Justus A; Knopik VS; McGeary J; Meyerson LA
Alcohol Clin Exp Res; 2013 Feb; 37(2):325-31. PubMed ID: 23136901
[TBL] [Abstract][Full Text] [Related]
26. Allele frequency and genotype distribution of the opioid receptor μ-1 (OPRM1) A118G polymorphism in the Western Saudi population.
Bagher AM; Hareeri RH
J Appl Biomed; 2023 Sep; 21(3):160-165. PubMed ID: 37747315
[TBL] [Abstract][Full Text] [Related]
27. Interaction Between the μ-Opioid Receptor Gene and the Number of Heavy-Drinking Peers on Alcohol Use.
Zaso MJ; Maisto SA; Glatt SJ; Belote JM; Park A
Alcohol Clin Exp Res; 2017 Dec; 41(12):2041-2050. PubMed ID: 28992386
[TBL] [Abstract][Full Text] [Related]
28. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
[TBL] [Abstract][Full Text] [Related]
29. Lack of associations of the opioid receptor mu 1 (OPRM1) A118G polymorphism (rs1799971) with alcohol dependence: review and meta-analysis of retrospective controlled studies.
Kong X; Deng H; Gong S; Alston T; Kong Y; Wang J
BMC Med Genet; 2017 Oct; 18(1):120. PubMed ID: 29070014
[TBL] [Abstract][Full Text] [Related]
30. OPRM1 Moderates Daily Associations of Naltrexone Adherence With Alcohol Consumption: Preliminary Evidence From a Mobile Health Trial.
Hendershot CS; Dermody SS; Wardell JD; Zaso MJ; Kennedy JL; Stoner SA
Alcohol Clin Exp Res; 2020 Apr; 44(4):983-991. PubMed ID: 32020635
[TBL] [Abstract][Full Text] [Related]
31. Interacting effects of naltrexone and OPRM1 and DAT1 variation on the neural response to alcohol cues.
Schacht JP; Anton RF; Voronin KE; Randall PK; Li X; Henderson S; Myrick H
Neuropsychopharmacology; 2013 Feb; 38(3):414-22. PubMed ID: 23032071
[TBL] [Abstract][Full Text] [Related]
32. OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence.
Coller JK; Cahill S; Edmonds C; Farquharson AL; Longo M; Minniti R; Sullivan T; Somogyi AA; White JM
Pharmacogenet Genomics; 2011 Dec; 21(12):902-5. PubMed ID: 21946895
[TBL] [Abstract][Full Text] [Related]
33. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
[TBL] [Abstract][Full Text] [Related]
34. The role of OPRM1 polymorphism in the etiology of alcoholism.
Samochowiec A; Samochowiec J; Pełka-Wysiecka J; Kucharska-Mazur J; Grochans E; Jabłoński M; Bieńkowski P; Murawiec S; Małecka I; Mak M; Kołodziej Ł; Heitzman J; Grzywacz A
Adv Clin Exp Med; 2019 Feb; 28(2):199-202. PubMed ID: 30085428
[TBL] [Abstract][Full Text] [Related]
35. The prevalence of ADH1B and OPRM1 alleles predisposing for alcohol consumption are increased in the Hungarian psoriasis population.
Szentkereszty-Kovács Z; Fiatal S; Szegedi A; Kovács D; Janka E; Herszényi K; Holló P; Nikamo P; Ståhle M; Remenyik É; Törőcsik D
Arch Dermatol Res; 2019 Aug; 311(6):435-442. PubMed ID: 31011876
[TBL] [Abstract][Full Text] [Related]
36. Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study.
Woodcock EA; Lundahl LH; Burmeister M; Greenwald MK
Am J Addict; 2015 Jun; 24(4):329-35. PubMed ID: 25911999
[TBL] [Abstract][Full Text] [Related]
37. Initial evidence of an association between OPRM1 and adolescent alcohol misuse.
Miranda R; Ray L; Justus A; Meyerson LA; Knopik VS; McGeary J; Monti PM
Alcohol Clin Exp Res; 2010 Jan; 34(1):112-22. PubMed ID: 19860800
[TBL] [Abstract][Full Text] [Related]
38. Dual growth of adolescent smoking and drinking: evidence for an interaction between the mu-opioid receptor (OPRM1) A118G polymorphism and sex.
Kleinjan M; Poelen EA; Engels RC; Verhagen M
Addict Biol; 2013 Nov; 18(6):1003-12. PubMed ID: 22260295
[TBL] [Abstract][Full Text] [Related]
39. Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial.
Anton RF; Voronin KE; Book SW; Latham PK; Randall PK; Glen WB; Hoffman M; Schacht JP
Alcohol Clin Exp Res; 2020 Oct; 44(10):2084-2096. PubMed ID: 32772383
[TBL] [Abstract][Full Text] [Related]
40. Effects of the Mu opioid receptor polymorphism (OPRM1 A118G) on pain regulation, placebo effects and associated personality trait measures.
Peciña M; Love T; Stohler CS; Goldman D; Zubieta JK
Neuropsychopharmacology; 2015 Mar; 40(4):957-65. PubMed ID: 25308352
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
